Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05035641 · ClinicalTrials.gov registry record · Phase 2
A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
A Phase 2 study of Renal Anemia, sponsored by Kind Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
- 8
- Study locations
NCT05035641 is a Phase 2 study of Renal Anemia that has completed, run by Kind Pharmaceuticals. The registered enrollment target is 113 participants. The trial reports 8 study locations across 8 states.
The verdict
NCT05035641, a Phase 2 study of Renal Anemia, has completed, sponsored by Kind Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients
Conditions Studied
Interventions
- DRUG Placebo
- DRUG AND017
Study Locations (8)
California
- Amicis Research Center - Northridge
Florida
- Clinical Site Partners - Winter Park
Louisiana
- Northwest Louisiana Nephrology - Shreveport
Michigan
- Elite Research Center - Flint
North Carolina
- Metrolina Nephrology Associates - Charlotte
Tennessee
- Southeast Renal Research Institute - Chattanooga
Texas
- Clinical Advancement Center, PLLC - San Antonio
Beijing Municipality
- Peking University People's Hospital - Beijing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2023-07-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05035641
The ClinicalTrials.gov registry entry for NCT05035641 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kind Pharmaceuticals, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Renal Anemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05035641 reports 8 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05035641 about?
NCT05035641 is a clinical study titled "A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients". This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients
What is the current status of trial NCT05035641?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2021-10-18. Estimated completion is 2023-07-24.
What conditions does trial NCT05035641 study?
This clinical trial studies the following conditions: Renal Anemia.
What interventions are being tested in trial NCT05035641?
The interventions under investigation include: Placebo (DRUG), AND017 (DRUG).
Who is sponsoring clinical trial NCT05035641?
This trial is sponsored by Kind Pharmaceuticals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05035641 being conducted?
This trial has 8 study locations across California, Florida, Louisiana, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
COMPLETED · Phase 4
-
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.